New treatment option for Cancer
Official title Impact of PEG Bowel Preparation on Gut Microbiome Composition Recovery
ClinicalTrials.gov ID: NCT06831539
What this study is testing
What is PEGLyte bowel preparation?
PEGLyte bowel preparation is an investigational medicine, being studied as a potential treatment for cancer.
Also referred to as PEG.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The main objective is to evaluate the impact of intestinal preparation on the composition, diversity and metabolome of the intestinal microbiota.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Healthy volunteer participant cohort:
- \> 18 years of age
- The participant has provided documented informed consent for the participation and to complete PEG bowel preparation and return collected stool...
You likely can't join if
- An ileus
- Significant gastric retention
- Suspected or established mechanical bowel obstruction
- Inflammatory or infectious gastrointestinal condition
- Neurologic or cognitive impairment that prevents safe swallowing
- Recent history (\<1 year) of cancer that still requires ongoing treatment
See the full eligibility criteria
- Healthy volunteer participant cohort:
- \> 18 years of age
- The participant has provided documented informed consent for the participation and to complete PEG bowel preparation and return collected stool samples.
- An ileus
- Significant gastric retention
- Suspected or established mechanical bowel obstruction
- Inflammatory or infectious gastrointestinal condition
- Neurologic or cognitive impairment that prevents safe swallowing
- Recent history (\<1 year) of cancer that still requires ongoing treatment
- Recent use of antibiotics 1 month prior to participation in the trial
- History of cardiac disease
- History of active renal dysfunction
- Presence of any absolute contraindication to PEG bowel preparation according to manufacturer labeling
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.